These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11731717)

  • 1. Reduction of submissive behavior in rats: a test for antidepressant drug activity.
    Malatynska E; Goldenberg R; Shuck L; Haque A; Zamecki P; Crites G; Schindler N; Knapp RJ
    Pharmacology; 2002 Jan; 64(1):8-17. PubMed ID: 11731717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model.
    Knapp RJ; Goldenberg R; Shuck C; Cecil A; Watkins J; Miller C; Crites G; Malatynska E
    Eur J Pharmacol; 2002 Apr; 440(1):27-35. PubMed ID: 11959085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Submissive Behavior Model for antidepressant drug activity testing: study using a video-tracking system.
    Pinhasov A; Crooke J; Rosenthal D; Brenneman D; Malatynska E
    Behav Pharmacol; 2005 Dec; 16(8):657-64. PubMed ID: 16286818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Submissive behavior in mice as a test for antidepressant drug activity.
    Malatynska E; Rapp R; Harrawood D; Tunnicliff G
    Pharmacol Biochem Behav; 2005 Oct; 82(2):306-13. PubMed ID: 16185758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of dominant or submissive behaviors as models for antimanic or antidepressant drug testing: technical considerations.
    Malatynska E; Pinhasov A; Crooke JJ; Smith-Swintosky VL; Brenneman DE
    J Neurosci Methods; 2007 Sep; 165(2):175-82. PubMed ID: 17645948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-submissive behavior as models of mania and depression.
    Malatynska E; Knapp RJ
    Neurosci Biobehav Rev; 2005; 29(4-5):715-37. PubMed ID: 15876455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
    Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
    Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
    Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective breeding for dominant and submissive behavior in Sabra mice.
    Feder Y; Nesher E; Ogran A; Kreinin A; Malatynska E; Yadid G; Pinhasov A
    J Affect Disord; 2010 Oct; 126(1-2):214-22. PubMed ID: 20427092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats.
    Ghorpade S; Tripathi R; Sonawane D; Manjrekar N
    J Basic Clin Physiol Pharmacol; 2011 Nov; 22(4):109-14. PubMed ID: 22865431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of HT-90B, a putative novel anxiolytic agent with potent antidepressive activity.
    Inagawa K; Tameda C; Uchida H; Miyauchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jan; 20(1):129-45. PubMed ID: 8861183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam.
    Rygula R; Abumaria N; Havemann-Reinecke U; Rüther E; Hiemke C; Zernig G; Fuchs E; Flügge G
    Behav Pharmacol; 2008 May; 19(3):183-96. PubMed ID: 18469536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antidepressant drugs on dominance behavior in rats competing for food.
    Malatyńska E; Kostowski W
    Pol J Pharmacol Pharm; 1984; 36(5):531-40. PubMed ID: 6543468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animals.
    Moussaieff A; Gross M; Nesher E; Tikhonov T; Yadid G; Pinhasov A
    J Psychopharmacol; 2012 Dec; 26(12):1584-93. PubMed ID: 23015543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of nuclear magnetic resonance-based metabonomics to the dominant-submissive rat behavioral model.
    Leo GC; Caldwell GW; Crooke J; Malatynska E; Cotto C; Hastings B; Scowcroft J; Hall J; Browne K; Hageman W
    Anal Biochem; 2005 Apr; 339(1):174-8. PubMed ID: 15766725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing Dominant-Submissive Behavior in Adult Rats Following Traumatic Brain Injury.
    Frank D; Gruenbaum BF; Semyonov M; Binyamin Y; Severynovska O; Gal R; Frenkel A; Knazer B; Boyko M; Zlotnik A
    J Vis Exp; 2022 Dec; (190):. PubMed ID: 36592002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes.
    Fell MJ; Witkin JM; Falcone JF; Katner JS; Perry KW; Hart J; Rorick-Kehn L; Overshiner CD; Rasmussen K; Chaney SF; Benvenga MJ; Li X; Marlow DL; Thompson LK; Luecke SK; Wafford KA; Seidel WF; Edgar DM; Quets AT; Felder CC; Wang X; Heinz BA; Nikolayev A; Kuo MS; Mayhugh D; Khilevich A; Zhang D; Ebert PJ; Eckstein JA; Ackermann BL; Swanson SP; Catlow JT; Dean RA; Jackson K; Tauscher-Wisniewski S; Marek GJ; Schkeryantz JM; Svensson KA
    J Pharmacol Exp Ther; 2011 Jan; 336(1):165-77. PubMed ID: 20947638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression.
    Overstreet DH; Naimoli VM; Griebel G
    Pharmacol Biochem Behav; 2010 Aug; 96(2):206-10. PubMed ID: 20470817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antidepressant effect of water decoction of Rhizoma acori tatarinowii in the behavioural despair animal models of depression].
    Li M; Chen H
    Zhong Yao Cai; 2001 Jan; 24(1):40-1. PubMed ID: 11341029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.